Thomas F. Szuran

Thomas F. Szuran

Sales & Marketing at GALENICA AG

Net worth: 674 855 $ as of 2024-03-30

57 year
Consumer Services
Distribution Services

Profile

Thomas F.
Szuran
is currently the President at Association Suisse des Producteurs des Specialitees Grand Pub since 2013 and the Chief Products & Marketing Officer at Galenica AG since 2019.
Previously, he served as the Chief Executive Officer at BioMed AG from 2011 to 2018, Sales Director at Pfizer AG from 2002 to 2005, Country Manager at Pfizer Pharmaceuticals Israel Ltd.
from 2005 to 2007, and Manager-Sales & Marketing at Abbott Laboratories GmbH (Switzerland) from 1997 to 2002.
He holds a doctorate degree from the Federal Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-12-30 8,083 ( 0.02% ) 674 855 $ 2024-03-30

Thomas F. Szuran active positions

CompaniesPositionStart
GALENICA AG Sales & Marketing 2020-12-31
Association Suisse des Producteurs des Specialitees Grand Pub President 2012-12-31
All active positions of Thomas F. Szuran

Former positions of Thomas F. Szuran

CompaniesPositionEnd
BioMed AG Chief Executive Officer 2017-12-31
Pfizer Pharmaceuticals Israel Ltd. Corporate Officer/Principal 2006-12-31
Pfizer AG Sales & Marketing 2004-12-31
Abbott Laboratories GmbH (Switzerland) Sales & Marketing 2001-12-31
See the detail of Thomas F. Szuran's experience

Training of Thomas F. Szuran

Federal Institute of Technology Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Thomas F. Szuran's experience

Connections

22

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
GALENICA AG

Distribution Services

Private companies5
BioMed AG

Pfizer AG

Pfizer Pharmaceuticals Israel Ltd.

Association Suisse des Producteurs des Specialitees Grand Pub

Abbott Laboratories GmbH (Switzerland)

See company connections
  1. Stock Market
  2. Insiders
  3. Thomas F. Szuran